Clinically relevant measures of fit? A note of caution.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  American Journal of Epidemiology

• Publication date

  2012-09-15

• Fields of study

  Medicine, Computer Science

• Identifiers
  DOI 10.1093/AJE/KWS208PMID 22875759PMCID PMC3530355
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Comments on ‘Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers’ by M. J. Pencina, R. B. D'Agostino, Sr. and E. W. Steyerberg

  2012cited by this paper
• Interpreting incremental value of markers added to risk prediction models.

  2012influential reference
• Consensus recommendations for risk stratification in multiple myeloma: report of the International Myeloma Workshop Consensus Panel 2.

  2011cited by this paper
• Performance of reclassification statistics in comparing risk prediction models

  2011influential reference
• One statistical test is sufficient for assessing new predictive markers

  2011cited by this paper
• Commentary: Reporting standards are needed for evaluations of risk reclassification.

  2011cited by this paper
• Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers

  2011cited by this paper
• Use of risk stratification to guide ambulatory management of neutropenic fever

  2011cited by this paper
• Assessment of Clinical Validity of a Breast Cancer Risk Model Combining Genetic and Clinical Information

  2010cited by this paper
• American society of clinical oncology clinical practice guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reduction.

  2009cited by this paper
• Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Detection, Evaluation, and Treatment of High Blood Cholesterol Education Program (NCEP) Expert Panel on Executive Summary of the Third Report of the National

  2009cited by this paper
• Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond

  2008cited by this paper
• Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score.

  2007cited by this paper
• Use and Misuse of the Receiver Operating Characteristic Curve in Risk Prediction

  2007cited by this paper
• Development and Validation of Improved Algorithms for the Assessment of Global Cardiovascular Risk in Women

  2007influential reference
• The Effect of Including C-Reactive Protein in Cardiovascular Risk Prediction Models for Women

  2006cited by this paper
• Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

  2002cited by this paper
• Risk stratification after acute myocardial infarction.

  1978cited by this paper
• Therapeutic decision making: a cost-benefit analysis.

  1975cited by this paper

• Artificial Intelligence-Enabled Prediction of Heart Failure Risk From Single-Lead Electrocardiograms.

  2025cites this paper
• Metabolomic Biomarkers Are Independently Associated With Secondary Adverse Cardiovascular Events in Patients With Coronary Artery Disease

  2025cites this paper
• Artificial Intelligence Enabled Prediction of Heart Failure Risk from Single-lead Electrocardiograms

  2024cites this paper
• Fractal analysis: Left ventricular trabecular complexity cardiac MRI adds independent risks for heart failure with preserved ejection fraction in participants with end-stage renal disease.

  2023cites this paper
• Transparent Reporting of a Multivariable Prediction Model for Individual Prognosis or Diagnosis (TRIPOD): Explanation and Elaboration. Translation into Russian

  2023cites this paper
• Cohen’s Kappa Coefficient as a Measure to Assess Classification Improvement following the Addition of a New Marker to a Regression Model

  2022cites this paper
• Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration. Russian translation

  2022cites this paper
• Net Reclassification Index Statistics Do Not Help Assess New Risk Models.

  2022cites this paper
• Genetic Biomarkers of Psychiatric Disease: Discriminating Bipolar Disorder From Major Depressive Disorder With Polygenic Risk Scores

  2020influential citation
• Early Pregnancy Prediction of Gestational Diabetes Mellitus Risk Using Prenatal Screening Biomarkers in Nulliparous Women.

  2020cites this paper
• Association of Body Shape Index (ABSI) with Hand Grip Strength

  2020cites this paper
• Single Measurements of Carboxy-Terminal Fibroblast Growth Factor 23 and Clinical Risk Prediction of Adverse Outcomes in CKD.

  2019cites this paper
• Application of net reclassification index to non-nested and point-based risk prediction models: a review.

  2018cites this paper
• Genetic prediction of type 2 diabetes using deep neural network

  2018influential citation
• Predicting Adherence to Chronic Disease Medications in Patients with Long-term Initial Medication Fills Using Indicators of Clinical Events and Health Behaviors

  2018cites this paper
• “Trending” statistical methods

  2018cites this paper
• Clinical worthlessness of genetic prediction of common forms of diabetes mellitus and related chronic complications: A position statement of the Italian Society of Diabetology.

  2017cites this paper
• Simpson's paradox in the integrated discrimination improvement

  2017cites this paper
• If too frail, functional benefit following cardiac surgery may fail: A role for prehabilitation?

  2017cites this paper
• Longitudinal Patterns of Spending Enhance the Ability to Predict Costly Patients: A Novel Approach to Identify Patients for Cost Containment

  2017cites this paper
• Identifying Persons at Increased Risk of Cardiovascular Disease

  2016cites this paper
• Investigating Predictive Disease Model Transportability through Cohort Simulation and Causal Analysis

  2016cites this paper
• Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and

  2015cites this paper
• Quantifying the value of biomarkers for predicting mortality.

  2015cites this paper
• Biomarkers of cardiomyocyte injury and stress identify left atrial and left ventricular remodelling and dysfunction: A population-based study.

  2015cites this paper
• Distinguishing bipolar from unipolar depression: the importance of clinical symptoms and illness features

  2015influential citation
• Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration

  2015cites this paper
• EXPLORATION OF NOVEL MECHANISMS AND BIOMARKERS FOR VENOUS THROMBOEMBOLISM - A GENETICS AND PROTEOMICS STUDY

  2015cites this paper
• Explained variation for recurrent event data

  2015cites this paper
• Tailoring the Implementation of New Biomarkers Based on Their Added Predictive Value in Subgroups of Individuals

  2015cites this paper
• Association between trajectories of statin adherence and subsequent cardiovascular events

  2015cites this paper
• Complex signals bioinformatics: evaluation of heart rate characteristics monitoring as a novel risk marker for neonatal sepsis

  2014cites this paper
• A note on the evaluation of novel biomarkers: do not rely on integrated discrimination improvement and net reclassification index

  2014cites this paper
• Improving long-term prediction of first cardiovascular event: the contribution of family history of coronary heart disease and social status.

  2014cites this paper
• Comparison of Lifestyle-Based and Traditional Cardiovascular Disease Prediction in a Multiethnic Cohort of Nonsmoking Women

  2014cites this paper
• Multiethnic Cohort of Nonsmoking Women Comparison of Lifestyle-Based and Traditional Cardiovascular Disease Prediction in a

  2014cites this paper
• Predicción del riesgo de Enfermedad Cardiovascular en la mujer: ¿Qué papel tienen los nuevos biomarcadores?

  2014cites this paper
• Net reclassification improvement and integrated discrimination improvement require calibrated models: relevance from a marker and model perspective

  2014cites this paper
• Comparison of Lifestyle Based to Traditional CVD Prediction in a Multiethnic Cohort of Non-Smoking Women

  2014cites this paper
• Cardiovascular disease risk prediction in women: is there a role for novel biomarkers?

  2014cites this paper
• Metabolic Syndrome Does Not Improve the Prediction of 5-Year Cardiovascular Disease and Total Mortality Over Standard Risk Markers. Prospective Population Based Study

  2014cites this paper
• Granulomatous mass adherent to a patent foramen ovale occluder.

  2013cites this paper
• Association of Novel Biomarkers of Cardiovascular Stress With Left Ventricular Hypertrophy and Dysfunction: Implications for Screening

  2013cites this paper
• Dysfunction : Implications for Screening Association of Novel Biomarkers of Cardiovascular Stress With Left Ventricular Hypertrophy

  2013cites this paper
• Net reclassification improvement: a link between statistics and clinical practice

  2013cites this paper
• Novel genetic markers improve measures of atrial fibrillation risk prediction

  2013cites this paper
• Adipocytokines, Hepatic and Inflammatory Biomarkers and Incidence of Type 2 Diabetes. The CoLaus Study

  2012cites this paper
• Pencina et al. respond to "The incremental value of new markers" and "Clinically relevant measures? A note of caution".

  2012cites this paper
• Clinical utility in evaluation of risk models.

  2012cites this paper
• Association of Novel Biomarkers of Cardiovascular Stress with Left Ventricular Hypertrophy and Dysfunction: Implications for Screening Association of Novel Biomarkers of Cardiovascular Stress with Left Ventricular Hypertrophy and Dysfunction: Implications for Screening

  year unknowncites this paper